Niki BioSolutions Enters into Strategic Agreement to Provide APOE Testing Services for Progressive Medical Research (PMR)

Niki BioSolutions' subsidiary DiamiR Biosciences entered into a strategic agreement to provide Progressive Medical Research (PMR) with APOE genotyping services to support their clinical research programs. The collaboration leverages Niki's CAP and CLEP-approved laboratory infrastructure to integrate high-quality genetic data into PMR's workflows for Alzheimer’s and cardiovascular studies.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.